Silco Pharmaceuticals Limited (DSE: SILCOPHL)

Market Cap	1.63B
Revenue (ttm)	421.83M
Net Income (ttm)	42.76M
Shares Out	103.81M
EPS (ttm)	0.41
PE Ratio	38.39
Forward PE	n/a
Dividend	0.10 (0.64%)
Ex-Dividend Date	Dec 9, 2024

Volume	307,728
Open	16.40
Previous Close	15.90
Day's Range	15.70 - 16.40
52-Week Range	15.40 - 24.60
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 31, 2024

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited manufactures and markets finished pharmaceutical products in Bangladesh. The company offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxatives, lipid lowering agents,...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 311
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In 2023, Silco Pharmaceuticals's revenue was 464.70 million, a decrease of -16.94% compared to the previous year's 559.47 million. Earnings were 69.22 million, a decrease of -18.03%.